Baranca Buijsers

429 total citations
9 papers, 286 citations indexed

About

Baranca Buijsers is a scholar working on Infectious Diseases, Molecular Biology and Nephrology. According to data from OpenAlex, Baranca Buijsers has authored 9 papers receiving a total of 286 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 3 papers in Molecular Biology and 2 papers in Nephrology. Recurrent topics in Baranca Buijsers's work include COVID-19 Clinical Research Studies (3 papers), Renal Diseases and Glomerulopathies (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Baranca Buijsers is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Renal Diseases and Glomerulopathies (2 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Baranca Buijsers collaborates with scholars based in Netherlands, United States and Germany. Baranca Buijsers's co-authors include Johan van der Vlag, Cansu Yanginlar, Quirijn de Mast, Marissa L. Maciej-Hulme, Mihai G. Netea, Raphaël Duivenvoorden, Luuk B. Hilbrands, Nils Rother, Leo A. B. Joosten and Tom Nijenhuis and has published in prestigious journals such as Frontiers in Immunology, Frontiers in Pharmacology and Advances in experimental medicine and biology.

In The Last Decade

Baranca Buijsers

9 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Baranca Buijsers Netherlands	7	139	77	61	51	46	9	286
Aline de Nooijer Netherlands	9	208 1.5×	114 1.5×	61 1.0×	89 1.7×	22 0.5×	12	389
Joram Huckriede Netherlands	6	65 0.5×	21 0.3×	70 1.1×	35 0.7×	22 0.5×	10	240
Alexander T. Fields United States	10	30 0.2×	33 0.4×	85 1.4×	32 0.6×	12 0.3×	18	294
Ottavio Zucchetti Italy	6	157 1.1×	76 1.0×	49 0.8×	39 0.8×	14 0.3×	11	284
Timothy Chevassut United Kingdom	6	160 1.2×	67 0.9×	38 0.6×	17 0.3×	54 1.2×	15	249
Sabrina Setembre Batah Brazil	9	157 1.1×	69 0.9×	88 1.4×	54 1.1×	6 0.1×	27	377
Shuang Qiu China	11	73 0.5×	8 0.1×	50 0.8×	29 0.6×	76 1.7×	24	429
J Izaak Miller United States	3	196 1.4×	89 1.2×	48 0.8×	32 0.6×	9 0.2×	3	317
Julys da Fonseca Palmeira Brazil	5	185 1.3×	79 1.0×	49 0.8×	27 0.5×	5 0.1×	9	286
Andrew C. Kwong Canada	6	26 0.2×	7 0.1×	82 1.3×	123 2.4×	8 0.2×	11	312

Countries citing papers authored by Baranca Buijsers

Since Specialization

Citations

This map shows the geographic impact of Baranca Buijsers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baranca Buijsers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baranca Buijsers more than expected).

Fields of papers citing papers by Baranca Buijsers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baranca Buijsers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baranca Buijsers. The network helps show where Baranca Buijsers may publish in the future.

Co-authorship network of co-authors of Baranca Buijsers

This figure shows the co-authorship network connecting the top 25 collaborators of Baranca Buijsers. A scholar is included among the top collaborators of Baranca Buijsers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baranca Buijsers. Baranca Buijsers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Buijsers, Baranca, et al.. (2023). Heparanase-2 protein and peptides have a protective effect on experimental glomerulonephritis and diabetic nephropathy. Frontiers in Pharmacology. 14. 1098184–1098184. 9 indexed citations

Buijsers, Baranca, et al.. (2023). Glycosaminoglycans and fucoidan have a protective effect on experimental glomerulonephritis. Frontiers in Molecular Biosciences. 10. 1223972–1223972. 5 indexed citations

Garsen, Marjolein, Baranca Buijsers, Toin H. Van Kuppevelt, et al.. (2023). Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria. EBioMedicine. 90. 104506–104506. 7 indexed citations

Rovas, Alexandros, Irina Osiaevi, Johan van der Vlag, et al.. (2022). Heparanase Is a Putative Mediator of Endothelial Glycocalyx Damage in COVID-19 – A Proof-of-Concept Study. Frontiers in Immunology. 13. 916512–916512. 11 indexed citations

Buijsers, Baranca, Rahajeng N. Tunjungputri, Gijs J. Overheul, et al.. (2021). Increased Plasma Heparanase Activity and Endothelial Glycocalyx Degradation in Dengue Patients Is Associated With Plasma Leakage. Frontiers in Immunology. 12. 759570–759570. 6 indexed citations

Rother, Nils, Cansu Yanginlar, Rik G.H. Lindeboom, et al.. (2020). Hydroxychloroquine Inhibits the Trained Innate Immune Response to Interferons. Cell Reports Medicine. 1(9). 100146–100146. 29 indexed citations

Buijsers, Baranca, Cansu Yanginlar, Aline de Nooijer, et al.. (2020). Increased Plasma Heparanase Activity in COVID-19 Patients. Frontiers in Immunology. 11. 575047–575047. 102 indexed citations

Buijsers, Baranca, Cansu Yanginlar, Marissa L. Maciej-Hulme, Quirijn de Mast, & Johan van der Vlag. (2020). Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients. EBioMedicine. 59. 102969–102969. 104 indexed citations

Vlag, Johan van der & Baranca Buijsers. (2020). Heparanase in Kidney Disease. Advances in experimental medicine and biology. 1221. 647–667. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact